Abstract: A sheet feeding apparatus includes a sheet supporting portion, a sheet feeding unit configured to perform a feeding operation, an air separation unit configured to perform a blowing operation, and a control unit configured to execute a sheet feeding control. In the sheet feeding control, in a case where a second number of sheets, separated by the blowing operation but not fed, remains on the sheet supporting portion at an end of a first job, and a number of printing sheets of a second job subsequent to the first job is a third number of sheets that is equal to or less than the second number of sheets, the control unit omits an initial blowing operation and starts the feed operation in the second job.

Abstract: A fluctuation attenuator has: a first flywheel 2 connected to an internal combustion engine ENG; a housing portion 7; a second flywheel 3 connected a transmission TM; a plurality of end portion sheets 10 inserted into the housing portion 7; and a coil spring 8 held on the end portion sheet 10. The end portion sheet 10 has an inserting hole 10a into which the coil spring 8 inserted, and a notched portion 10b into which a projecting piece 12a of the second flywheel 3 is inserted and with which the inserting hole 10a is communicated, and which exposes the end portion of the coil spring 8. A notched portion 10b is notched such that the projecting piece 12a contacts the end portion sheet 10 after contacting the coil spring 8 when the projecting piece 12a contacts the end portion sheet 10.

Abstract: A torque transmission apparatus including a first rotor, a second rotor, an elastic body deployed in a torque transmission path between the first rotor and the second rotor to absorb torque fluctuation between the first and second rotors, and a pair of seat members. The pair of seat members include holding portions for holding ends of the elastic body at one end surfaces and contact surfaces at the other end surfaces, and the contact surfaces are formed into convex curved surfaces so as to rollably contact concave curved lateral end surfaces of a housing of the first rotor and concave curved lateral end surfaces of projecting portions of the second rotor.

Abstract: A torque transmission apparatus including a first rotor, a second rotor, an elastic body deployed in a torque transmission path between the first rotor and the second rotor to absorb torque fluctuation between the first and second rotors, and a seat member interposed between the elastic body and the first and second rotors. The seat member includes a holding portion the elastic body at one circumferential end face and a contact surface contactable with a lateral end surface provided in the first rotor and the second rotor at the other circumferential end face, and is formed so that an angle of the contact surface is greater than 90°.

Abstract: A damper comprised of a first rotary member; a second rotary member; at least one elastic member that transmits torque between the first rotary member and the second rotary member; a first seat member disposed between the elastic member, and a first abutment portion of the first rotary member and a second abutment portion of the second rotary member on a counter-rotating direction side of the first rotary member; a second seat member disposed between the elastic member, and the first abutment portion and the second abutment portion on a rotating direction side of the first rotary member; and a sticking preventing mechanism, which converts part of a radially outward force generated by a centrifugal force into a restoring force of the elastic member in the circumferential direction.

Abstract: A synchronizer comprising: a hub including splines; a sleeve including internal splines; a transmission gear including external splines; a blocking ring including dog teeth, a notch and a preceding projecting member, wherein after the hub and the transmission gear are synchronized, the preceding projecting member is pressed by the internal splines, and engaged with the external splines before the internal splines.

Abstract: A torque transmission apparatus including a first rotor, a second rotor, an elastic body deployed in a torque transmission path between the first rotor and the second rotor to absorb torque fluctuation between the first and second rotors, and a pair of seat members. The pair of seat members include holding portions for holding ends of the elastic body at one end surfaces and contact surfaces at the other end surfaces, and the contact surfaces are formed into convex curved surfaces so as to rollaby contact concave curved lateral end surfaces of a housing of the first rotor and concave curved lateral end surfaces of projecting portions of the second rotor.

Abstract: A torque transmission apparatus including a first rotor, a second rotor, an elastic body deployed in a torque transmission path between the first rotor and the second rotor to absorb torque fluctuation between the first and second rotors, and a seat member interposed between the elastic body and the first and second rotors. The seat member includes a holding portion the elastic body at one circumferential end face and a contact surface contactable with a lateral end surface provided in the first rotor and the second rotor at the other circumferential end face, and is formed so that an angle of the contact surface is greater than 90°.

Abstract: A fluctuation attenuator has: a first flywheel 2 connected to an internal combustion engine ENG; a housing portion 7; a second flywheel 3 connected a transmission TM; a plurality of end portion sheets 10 inserted into the housing portion 7; and a coil spring 8 held on the end portion sheet 10. The end portion sheet 10 has an inserting hole 10a into which the coil spring 8 inserted, and a notched portion 10b into which a projecting piece 12a of the second flywheel 3 is inserted and with which the inserting hole 10a is communicated, and which exposes the end portion of the coil spring 8. A notched portion 10b is notched such that the projecting piece 12a contacts the end portion sheet 10 after contacting the coil spring 8 when the projecting piece 12a contacts the end portion sheet 10.

Abstract: One embodiment provides a damper including: a first rotary member; a second rotary member; at least one elastic member that transmits torque between the first rotary member and the second rotary member; a first seat member disposed between the elastic member, and a first abutment portion of the first rotary member and a second abutment portion of the second rotary member on a counter-rotating direction side of the first rotary member; a second seat member disposed between the elastic member, and the first abutment portion and the second abutment portion on a rotating direction side of the first rotary member; and a sticking preventing mechanism, which converts part of a radially outward force generated by a centrifugal force into a restoring force of the elastic member in the circumferential direction.

Abstract: A synchronizer comprising: a hub including splines; a sleeve including internal splines; a transmission gear including external splines; a blocking ring including dog teeth, a notch and a preceding projecting member, wherein after the hub and the transmission gear are synchronized, the preceding projecting member is pressed by the internal splines, and engaged with the external splines before the internal splines.

Abstract: Provided is an aromatic ring compound having a glucagon antagonistic action, which is useful for the prophylaxis or treatment of diabetes and the like. A compound represented by the formula (I): wherein each symbol is as defined in the DESCRIPTION, or a salt thereof has a superior glucagon antagonistic action, and is useful as a glucagon antagonist, a glucose production inhibitor or an agent for the prophylaxis or treatment of diabetes and the like.

Abstract: Provided is an aromatic ring compound having a glucagon antagonistic action, which is useful for the prophylaxis or treatment of diabetes and the like. A compound represented by the formula (I): wherein each symbol is as defined in the DESCRIPTION, or a salt thereof has a superior glucagon antagonistic action, and is useful as a glucagon antagonist, a glucose production inhibitor or an agent for the prophylaxis or treatment of diabetes and the like.

Abstract: A dialogue control system that uses an ontology that systematically expresses domain knowledge representing concepts and relationships between concepts to determine questions for a user and implements the questions, and implements a dialogue in accordance with received user answers. One or more dimension-classified ontologies and a basic ontology are stored, a concept from a user response is specified as a condition, and one or a plural number of the dimension-classified ontologies that meet the specified condition are fetched. The content of the fetched dimension-classified ontology/ies is overwritten on the basic ontology, in order according to dimension priorities from the dimension-classified ontology with the lowest dimension priority, and a multidimensional ontology is generated. The dialogue control system uses this multidimensional ontology to control the dialogue.

Abstract: The present invention provides an indole derivative having a melanin-concentrating hormone receptor antagonistic action, which is useful as an agent for the prophylaxis or treatment of obesity and the like. The present invention relates to a compound represented by the formula (I): wherein each symbol is as defined in the specification, or a salt thereof.

Abstract: The present invention provides a compound having a melanin-concentrating hormone receptor antagonistic action and low toxicity, which is useful as an agent for the prophylaxis or treatment of obesity and the like. The present invention relates to a compound represented by the formula (I): wherein each symbol is as defined in the specification, or a salt thereof.

Abstract: The present invention provides an indole derivative having a melanin-concentrating hormone receptor antagonistic action, which is useful as an agent for the prophylaxis or treatment of obesity and the like. The present invention relates to a compound represented by the formula (I): wherein each symbol is as defined in the specification, or a salt thereof.

Abstract: The present invention relates to a sulfonamide derivative which is useful as an active ingredient of pharmaceutical preparations. The sulfonamide derivatives of the present invention have CCR3 (CC type chemokine receptor) antagonistic activity, and can be used for the prophylaxis and treatment of diseases associated with CCR3 activity, in particular for the treatment of asthma, atopic dermatitis, allergic rhinitis and other inflammatory/immunological disorders.

Abstract: A liquid chemical discharge valve which includes a diaphragm valve having a contact portion for varying that varies a flow condition between the liquid chemical supply port and the liquid chemical discharge port by manipulating a lift amount, which is a distance between the contact portion and one of the liquid chemical supply port and the liquid chemical discharge port, between a closed valve condition and a maximum lift amount. The liquid chemical discharge valve includes an actuator unit for driving the contact portion in accordance with a supply pressure of the operating gas supplied from the operating gas supply port, to thereby manipulate the lift amount. The actuator unit includes a lift amount limiting unit for limiting the maximum lift amount adjustably.

Abstract: The present invention relates to novel fused azolepyrimidine derivatives, processes for preparing them and pharmaceutical preparations containing them. The fused azolepyrimidine derivatives of the present invention exhibit enhanced potency for phosphotidylinositol-3-kinase (PI3K) inhibition, especially for PI3K-? inhibition and can be used for the prophylaxis and treatment of diseases associated with PI3K and particularly with PI3K-? activity. More specifically, the azole derivatives of the present invention are useful for treatment and prophylaxis of diseases as follows: inflammatory and immunoregulatory disorders, such as asthma, atopic dermatitis, rhinitis, allergic diseases, chronic obstructive pulmonary disease (COPD), septic shock, joint diseases, autoimmune pathologies such as rheumatoid arthritis, and Graves' disease, cancer, myocardial contractility disorders, heart failure, thromboembolism, ischemia, and atherosclerosis.